PMID- 28792113 OWN - NLM STAT- MEDLINE DCOM- 20190724 LR - 20210517 IS - 1751-7893 (Electronic) IS - 1751-7885 (Linking) VI - 13 IP - 2 DP - 2019 Apr TI - The role of a family history of psychosis for youth at clinical high risk of psychosis. PG - 251-256 LID - 10.1111/eip.12471 [doi] AB - AIM: On average, there is a 10% to 12% likelihood of developing a psychotic disorder solely based on being at familial high risk. However, the introduction of the criteria for clinical high risk (CHR) of psychosis suggested for CHR individuals, 20% to 30% will go on to develop a full-blown psychotic illness within 3 years. Several studies suggest a role for family history in conversion to psychosis among those at CHR. However, we know very little about those who meet the CHR criteria and have a positive family history for psychosis compared to those at CHR with no known family history. The aim of this study was to compare these 2 groups on demographics, clinical symptoms, social and role functioning, IQ, environmental factors and conversion to psychosis. METHOD: A total of 762 participants met criteria for being at CHR, 119 of whom had a family history (CHR + FH) and 643 without (CHR-FH). Groups were compared on attenuated symptoms, role and social functioning, IQ, past trauma, perceived discrimination and cannabis use. Survival analysis was used to compare groups on conversion rates. RESULTS: There were no major differences between the groups in symptoms, functioning, IQ, cannabis use or in the rate of conversion between the groups. The CHR + FH group reported increased amounts of early trauma. CONCLUSION: There is a possibility that CHR + FH individuals believe that it is more difficult for them to cope with circumstances such as abuse or potential abuse. Future research on this subject should investigate family environment and its role in conversion to psychosis among CHR + FH individuals. CI - (c) 2017 John Wiley & Sons Australia, Ltd. FAU - Georgopoulos, Grace AU - Georgopoulos G AD - Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada. FAU - Stowkowy, Jacqueline AU - Stowkowy J AD - Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada. FAU - Liu, Lu AU - Liu L AD - Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada. FAU - Cadenhead, Kristin S AU - Cadenhead KS AD - Department of Psychiatry, University of California San Diego, La Jolla, California. FAU - Cannon, Tyrone D AU - Cannon TD AD - Department of Psychology, Yale University, New Haven, Connecticut. FAU - Cornblatt, Barbara A AU - Cornblatt BA AD - Department of Psychiatry, Zucker Hillside Hospital, Queens, New York. FAU - McGlashan, Thomas H AU - McGlashan TH AD - Department of Psychiatry, Yale University, New Haven, Connecticut. FAU - Perkins, Diana O AU - Perkins DO AD - Department of Psychiatry, University of North Carolina, Chapel Hill, North Carolina. FAU - Seidman, Larry J AU - Seidman LJ AD - Department of Psychiatry, Harvard Medical School at Beth Israel Deaconess Medical Center and Massachusetts General Hospital, Boston, Massachusetts. FAU - Tsuang, Ming T AU - Tsuang MT AD - Department of Psychiatry, University of California San Diego, La Jolla, California. AD - Institute of Genomic Medicine, University of California, La Jolla, California. FAU - Walker, Elaine F AU - Walker EF AD - Department of Psychology, Emory University, Atlanta, Georgia. FAU - Woods, Scott W AU - Woods SW AD - Department of Psychiatry, Yale University, New Haven, Connecticut. FAU - Bearden, Carrie E AU - Bearden CE AD - Department of Psychiatry and Biobehavioral Sciences and Psychology, University of California, Los Angeles, Los Angeles, California. FAU - Mathalon, Daniel H AU - Mathalon DH AD - Department of Psychiatry, University of California, San Francisco, San Francisco, California. AD - Psychiatry Service, San Francisco, California. FAU - Addington, Jean AU - Addington J AD - Hotchkiss Brain Institute, Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada. LA - eng GR - U01MH08185705/MH/NIMH NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20170809 PL - Australia TA - Early Interv Psychiatry JT - Early intervention in psychiatry JID - 101320027 MH - Adolescent MH - Female MH - Genetic Predisposition to Disease/*genetics MH - Humans MH - Likelihood Functions MH - Longitudinal Studies MH - Male MH - North America MH - Prodromal Symptoms MH - Psychotic Disorders/diagnosis/*genetics/psychology MH - Risk Assessment MH - Social Adjustment MH - Substance-Related Disorders MH - Surveys and Questionnaires MH - Survival Analysis MH - Young Adult OTO - NOTNLM OT - *family risk OT - *prodromal OT - *psychosis EDAT- 2017/08/10 06:00 MHDA- 2019/07/25 06:00 CRDT- 2017/08/10 06:00 PHST- 2016/08/08 00:00 [received] PHST- 2017/05/01 00:00 [revised] PHST- 2017/06/17 00:00 [accepted] PHST- 2017/08/10 06:00 [pubmed] PHST- 2019/07/25 06:00 [medline] PHST- 2017/08/10 06:00 [entrez] AID - 10.1111/eip.12471 [doi] PST - ppublish SO - Early Interv Psychiatry. 2019 Apr;13(2):251-256. doi: 10.1111/eip.12471. Epub 2017 Aug 9.